|
|
|
|
| LEADER |
01000cam a2200265 4500 |
| 001 |
1772461164 |
| 003 |
DE-627 |
| 005 |
20240214201719.0 |
| 007 |
tu |
| 008 |
211005s2022 xxu||||| 00| ||eng c |
| 010 |
|
|
|a 2021043883
|
| 020 |
|
|
|a 9781119722861
|c paperback
|9 978-1-119-72286-1
|
| 035 |
|
|
|a (DE-627)1772461164
|
| 035 |
|
|
|a (DE-599)KXP1772461164
|
| 035 |
|
|
|a (OCoLC)1296330169
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rda
|
| 041 |
|
|
|a eng
|
| 044 |
|
|
|c XD-US
|
| 050 |
|
0 |
|a RS403
|
| 082 |
0 |
|
|a 615.1/9
|q LOC
|
| 084 |
|
|
|a VS 7000
|q DE-16
|2 rvk
|0 (DE-625)rvk/147697:253
|
| 100 |
1 |
|
|a Harrington, Peter J.
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Routes to essential medicines
|b a workbook for organic synthesis
|c Peter J. Harrington, Better Pharma Processes, LLC, Louisville, CO, USA
|
| 264 |
|
1 |
|a Hoboken, NJ
|b Wiley
|c 2022
|
| 300 |
|
|
|a xvii, 493 Seiten
|b Illustrationen
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 520 |
|
|
|a "Organic synthesis concentrates on the building of organic compounds. The process involves using simple molecules to construct complex organic molecules. Due to its intricate nature, organic synthesis is considered one of the most important branches of organic chemistry. It allows chemists to create new structures with the potential to solve real world problems. The discovery of new organic compounds that can be utilized for biomedical purposes is significant to medicinal chemical research. Pharmaceutical development benefits largely from the study of organic synthesis and there is high demand for new synthetic methodologies"--
|
| 650 |
|
0 |
|a Pharmaceutical chemistry
|
| 650 |
|
0 |
|a Drugs
|x Synthesis
|
| 776 |
1 |
|
|z 9781119722878
|c (adobe pdf)
|
| 776 |
1 |
|
|z 9781119722830
|c (epub)
|
| 776 |
0 |
8 |
|i Erscheint auch als
|n Online-Ausgabe
|a Harrington, Peter J
|t Routes to essential medicines
|d Hoboken, NJ : Wiley, 2021
|w (DLC)2021043884
|
| 856 |
4 |
2 |
|u https://www.gbv.de/dms/bowker/toc/9781119722861.pdf
|v 2022-07-28
|x Aggregator
|3 Inhaltsverzeichnis
|
| 912 |
|
|
|a GBV_ILN_2011
|
| 912 |
|
|
|a ISIL_DE-16
|
| 912 |
|
|
|a SYSFLAG_1
|
| 912 |
|
|
|a GBV_KXP
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 936 |
r |
v |
|a VS 7000
|b Allgemeines
|k Chemie und Pharmazie
|k Pharmazeutische Chemie und Molekularpharmakologie
|k Einzelne Arzneimittel- und Wirkstoffgruppen
|k Übergreifende Literatur
|k Allgemeines
|0 (DE-627)1271896176
|0 (DE-625)rvk/147697:253
|0 (DE-576)201896176
|
| 951 |
|
|
|a BO
|
| 953 |
|
|
|2 045F
|a 615.1/9
|
| 980 |
|
|
|2 2011
|1 01
|x DE-16
|b 4063050025
|c 00
|f --%%--
|d UBN/VS 7000 H299
|e --%%--
|j --%%--
|y l01
|z 18-02-22
|
| 984 |
|
|
|2 2011
|1 01
|x DE-16
|a 106688382
|
